Holen Sie sich die Stockscreener-App
4.22
1.86%
-0.08
Handel nachbörslich:
4.45
0.23
+5.45%
Briacell Therapeutics Corp Aktie (BCTX) Neueste Nachrichten
Published on: 2026-03-12 08:04:05 - baoquankhu1.vn
Take Profit: Is BriaCell Therapeutics Corp Equity Warrant benefiting from innovation trends2026 Buyback Activity & Daily Entry Point Trade Alerts - baoquankhu1.vn
BriaCell Therapeutics Corp. 2026 Q2 Financial Results and Nasdaq Listing Overview - Minichart
Why did BCTX stock surge 50% today? - MSN
BriaCell Therapeutics Corp. Files Form 8-K: Company Details, NASDAQ Ticker Symbols, and Key Disclosures (March 2026) 343637 - Minichart
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting - GlobeNewswire
BriaCell Shareholders Approve Auditors and Reelect Board - TipRanks
Why retail investors favor BriaCell Therapeutics Corp. stock2026 Earnings Impact & Real-Time Chart Pattern Alerts - Naître et grandir
IPO Launch: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Stock Analysis & High Accuracy Trade Signal Alerts - baoquankhu1.vn
What sentiment indicators say about BriaCell Therapeutics Corp. Equity Warrant stock2025 Price Action Summary & Free High Return Stock Watch Alerts - Naître et grandir
Market Pulse: What is the next catalyst for BriaCell Therapeutics Corp2025 Bull vs Bear & Precise Buy Zone Identification - baoquankhu1.vn
Why is BriaCell Therapeutics Corp stock going downQuarterly Growth Report & Short-Term High Return Ideas - baoquankhu1.vn
Merger Talk: How does BriaCell Therapeutics Corp Equity Warrant compare to its peersWeekly Volume Report & Weekly Momentum Stock Picks - baoquankhu1.vn
How To Trade (BCT) (BCT:CA) - Stock Traders Daily
Retail Trends: Does BriaCell Therapeutics Corp align with a passive investing strategy2025 Market Sentiment & Growth-Oriented Investment Plans - baoquankhu1.vn
BriaCell Shareholders Overwhelmingly Back Board and Auditors at Annual Meeting - TipRanks
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting - The Manila Times
Aug Retail: Can BriaCell Therapeutics Corp ride the EV waveEntry Point & Smart Money Movement Alerts - baoquankhu1.vn
AI Stocks: Is Putnam Master Intermediate Income Trust stock risky to hold nowMarket Sentiment Report & Real-Time Market Trend Scan - baoquankhu1.vn
BriaCell Therapeutics: Key Catalysts on the Horizon for Investors - AD HOC NEWS
Trading (BCT) With Integrated Risk Controls (BCT:CA)Stock Traders Daily Canada - Stock Traders Daily
EPS Watch: Is BriaCell Therapeutics Corp a defensive stockEarnings Risk Summary & Smart Investment Allocation Tips - baoquankhu1.vn
BCTXZBriacell Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
(BCT) Equity Trading Insights (BCT:CA) - Stock Traders Daily
BCTXBriacell Therapeutics Corp Latest Stock News & Market Updates - Stock Titan
Basic earnings per share (basic EPS) of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Price to earnings ratio of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
Number of employees of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
BCTXL | BriaCell Therapeutics Corp. Warrant Institutional Ownership - Quiver Quantitative
BCTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BCTXW SEC FilingsBriacell Therapeutics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Net income of BriaCell Therapeutics Corp. – NASDAQ:BCTXZ - TradingView
BCTXW Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Street Watch: Is BriaCell Therapeutics Corp a defensive stock2025 Performance Recap & Capital Efficiency Focused Ideas - baoquankhu1.vn
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License - National Today
BCTXZ Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BriaCell spins off sCD80 cancer therapy to BriaPro in strategic deal - Indian Pharma Post
BriaCell Restructures Soluble CD80 Program via BriaPro Deal - TipRanks
BriaCell enters asset sale to BriaPro for sCD80, receives 23.97M shares and up to $3M credit - TradingView
(BCT) Investment Performance Report (BCT:CA)Stock Traders Daily Canada - Stock Traders Daily
Is BriaCell Therapeutics Corp. stock a top pick in earnings seasonJuly 2025 Catalysts & Risk Adjusted Buy and Sell Alerts - mfd.ru
Bull Run: What is BriaCell Therapeutics Corp. Equity Warrant’s valuation compared to sector2025 Geopolitical Influence & Weekly Setup with High ROI Potential - mfd.ru
BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study - Intellectia AI
BriaCell (BCTX) Expands Biologic Cancer Treatments Through New A - GuruFocus
BriaPro to Acquire BriaCell’s Soluble CD80 License in Strategic Cancer Immunotherapy Deal - TipRanks
Briacell, Briapro enter into asset purchase agreement for exclusive soluble CD80 license - marketscreener.com
BriaCell Therapeutics Brief: BriaCell and BriaPro Entering Into Asset Purchase Agreement for Exclusive Soluble CD80 License - marketscreener.com
Will BriaCell Therapeutics Corp. Equity Warrant stock maintain momentum in 2025Market Activity Report & Verified Chart Pattern Signals - mfd.ru
BriaCell Therapeutics Corp. Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer - marketscreener.com
(BCT) Technical Patterns and Signals (BCT:CA) - Stock Traders Daily
BriaCell Wins Fifth Straight Safety Nod for Fast-Track Phase 3 Breast Cancer Trial - TipRanks
BriaCell Therapeutics' Phase 3 Breast Cancer Treatment Trial Gets Fifth DSMB Recommendation to Continue - marketscreener.com
Data Safety Review Board Issues Positive Safety Recommendation For BriaCell's Phase 3 Study - marketscreener.com
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer - The Manila Times
BriaCell Receives Positive Recommendation from Data Safety - GlobeNewswire
BriaCell Awarded New Zealand Patent for its Whole Cell Technology - Intellectia AI
Why BriaCell Therapeutics Corp. stock could be next big winnerTrade Exit Summary & High Conviction Buy Zone Alerts - mfd.ru
What is BriaCell Therapeutics Corp. Equity Warrant s debt to equity ratioJuly 2025 Spike Watch & Consistent Return Investment Signals - mfd.ru
Entry Recap: Will BriaCell Therapeutics Corp. stock go up in YEARTrade Risk Report & Long-Term Safe Investment Ideas - mfd.ru
Is now the right time to enter BriaCell Therapeutics Corp.2025 Fundamental Recap & Risk Controlled Daily Plans - mfd.ru
Will BriaCell Therapeutics Corp. Equity Warrant announce a stock splitJuly 2025 Rallies & Daily Volume Surge Signals - mfd.ru
Can BriaCell Therapeutics Corp. stock maintain growth trajectoryPrice Action & Free Low Drawdown Momentum Trade Ideas - mfd.ru
Published on: 2026-02-14 21:45:18 - mfd.ru
Does BriaCell Therapeutics Corp. Equity Warrant have pricing powerMarket Activity Report & Technical Confirmation Alerts - mfd.ru
BCTX Should I Buy - Intellectia AI
BCTX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):